Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Clinical trial NCT03711058 · COMPLETED

Trial details

NCT number: NCT03711058
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor Microsatellite Stable (MSS) Colon Cancer

Start date: 2019-01-17
Primary completion: 2022-06-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.